NZ545365A - Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for treating cutaneous and other exocrine gland diseases - Google Patents

Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for treating cutaneous and other exocrine gland diseases

Info

Publication number
NZ545365A
NZ545365A NZ545365A NZ54536504A NZ545365A NZ 545365 A NZ545365 A NZ 545365A NZ 545365 A NZ545365 A NZ 545365A NZ 54536504 A NZ54536504 A NZ 54536504A NZ 545365 A NZ545365 A NZ 545365A
Authority
NZ
New Zealand
Prior art keywords
composition
composition according
sodium chloride
skin
substance
Prior art date
Application number
NZ545365A
Other languages
English (en)
Inventor
Warren Ward
Original Assignee
Warren Ward
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warren Ward filed Critical Warren Ward
Priority claimed from PCT/GB2004/003104 external-priority patent/WO2005013942A1/en
Publication of NZ545365A publication Critical patent/NZ545365A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NZ545365A 2003-07-19 2004-07-19 Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for treating cutaneous and other exocrine gland diseases NZ545365A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0316940A GB0316940D0 (en) 2003-07-19 2003-07-19 Treatment of skin and other medical conditions
GB0327006A GB0327006D0 (en) 2003-07-19 2003-11-20 Drug compositon and therapeutics
PCT/GB2004/003104 WO2005013942A1 (en) 2003-07-19 2004-07-19 Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for treating cutaneous and other exocrine gland diseases

Publications (1)

Publication Number Publication Date
NZ545365A true NZ545365A (en) 2009-10-30

Family

ID=27772314

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ545365A NZ545365A (en) 2003-07-19 2004-07-19 Compositions comprising components coated with a liquid impermeable but gas permeable layer, use thereof for treating cutaneous and other exocrine gland diseases

Country Status (10)

Country Link
JP (1) JP2012167103A (zh)
CN (2) CN1826102A (zh)
DK (1) DK1656120T3 (zh)
EA (1) EA011854B1 (zh)
ES (1) ES2399269T3 (zh)
GB (2) GB0316940D0 (zh)
IL (1) IL173227A (zh)
NZ (1) NZ545365A (zh)
PT (1) PT1656120E (zh)
ZA (1) ZA200601414B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014184704A1 (en) 2013-05-14 2014-11-20 Activesignal Holding Limited Device for the Treatment of Bone Conditions

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102198119A (zh) * 2011-05-27 2011-09-28 翟建鹏 外用药贴
CN103599093B (zh) 2013-11-18 2016-06-01 中国医学科学院生物医学工程研究所 一种抗hpv药物制剂及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2119244A (en) * 1982-04-30 1983-11-16 Alza Corp Potassium replacement therapy
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US6143211A (en) * 1995-07-21 2000-11-07 Brown University Foundation Process for preparing microparticles through phase inversion phenomena
EP1429747A4 (en) * 2001-07-10 2005-01-05 Kos Life Sciences Inc CORE FORMULATION WITH PIOGLITAZONE HYDROCHLORIDE AND A BIGUANIDE

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014184704A1 (en) 2013-05-14 2014-11-20 Activesignal Holding Limited Device for the Treatment of Bone Conditions

Also Published As

Publication number Publication date
ZA200601414B (en) 2007-04-25
CN102973946B (zh) 2015-03-18
GB0327006D0 (en) 2003-12-24
GB0316940D0 (en) 2003-08-27
DK1656120T3 (da) 2013-03-11
JP2012167103A (ja) 2012-09-06
IL173227A0 (en) 2006-06-11
EA011854B1 (ru) 2009-06-30
EA200600269A1 (ru) 2006-08-25
CN1826102A (zh) 2006-08-30
IL173227A (en) 2013-10-31
CN102973946A (zh) 2013-03-20
ES2399269T3 (es) 2013-03-27
PT1656120E (pt) 2013-02-18

Similar Documents

Publication Publication Date Title
US20130142851A1 (en) Compositions Comprising Components Coated With a Liquid Impermeable but Gas Permeable Layer, Use Thereof for Treating Cutaneous and Other Exocrine Gland Diseases
EP0103836B1 (en) Dietary and pharmaceutical compositions comprising methylsulfonylmethane
JP4592041B2 (ja) 生活の質を改善する新規食品の製造法および用途
US4559329A (en) Dietary and pharmaceutical uses of methyl-sulfonylmethane and compositions comprising it
JP3806427B2 (ja) 新規鎮痛剤
Namdev et al. Floating Drug Delivery Systems: An emerging trend for the treatment of peptic ulcer
JP5828609B2 (ja) 持続性解熱鎮痛消炎剤
JP2012167103A (ja) 液体不透過性であるが気体透過性の層で被覆した成分を具える組成物、皮膚およびその他の外分泌腺疾病の治療へのこの組成物の使用
EP3884942B1 (en) Use of bulleyaconitine a for treating skin disorders
JP2008044879A (ja) ラクトフェリンを含有する医薬組成物ならびに加工食品
MXPA06000741A (es) Composiciones que comprenden componentes recubiertos con una capa impermeable al liquido pero permeable al gas, su uso para el tratamiento de enfermedades cutaneas y otras de glandulas exocrinas
CN101347463A (zh) 一种用于预防复发和治疗胃溃疡的药物组合物
JP2010248219A (ja) 生活の質を改善する新規医薬組成物ならびに新規食品の製法および用途
KR19980043965A (ko) 종합김기약 및 그의 제조방법
WO2017028775A1 (zh) 贻贝粘蛋白用于粘膜的防护
KR20010045320A (ko) 급만성 위염 및 소화성 궤양 치료용 약학적 조성물
NZ730379A (en) Eutectic formulations of cyclobenzaprine hydrochloride
TW200824710A (en) Oral solid composition reduced in stimulation to the castrointestinal tract

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 19 JUL 2017 BY PIPERS

Effective date: 20140711

LAPS Patent lapsed